PE
EVH icon

Point72 Europe’s Evolent Health EVH Stock Holding History

Point72 Europe’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$35.2K Buy
+4,167
New +$40.4K ﹤0.01% 408

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Point72 Europe's EVH Position: Q3 2025 in Review

Point72 Europe opened a new position in Evolent Health (EVH) in Q3 2025: 4,167 shares worth $35.2K. The stake represents ﹤0.01% of the portfolio and ranks #408 among its holdings.

240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Point72 Europe held 4,167 shares of Evolent Health worth $35.2K as of Q3 2025.
  • Evolent Health was a new Point72 Europe position in Q3 2025.
  • Evolent Health made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #408 holding.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.